Navigation Links
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis
Date:6/17/2008

rovera injection every 3 months. After completing the 6-month treatment phase, subjects continue in the blinded trial for additional DXA, safety and clinical evaluations at 6 and 12 months post treatment per Food and Drug Administration (FDA) recommendations. The collection of treatment phase data, quality control processing and statistical analyses will take place over the upcoming weeks. As announced previously, Neurocrine is on track to report this treatment phase topline data in early September 2008.

The Petal Study will contribute to the extensive data set of 10 Phase I studies, 2 Phase IIa studies and 3 Phase IIb studies that will serve as the basis for end-of-phase II discussions anticipated in 2009 with the Division of Reproductive and Urologic Drug Products at the FDA.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia (BPH) and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program and R & D pipeline and Company overall. Specifically, the risks and uncertainties the Company faces with respect to the Company's GnRH program include, but are
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences Reports First Quarter 2008 Results
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
3. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
4. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
5. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
6. Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
7. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
8. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
9. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
10. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
11. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) invites ... Morgan Stanley Global Healthcare Conference on September 8, 2014, ... to listen to the live discussion via the internet ... at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of the ... the live event and accessible at the links above ...
(Date:8/27/2014)... -- An experimental drug designed to help regulate the blood,s ... anemia of inflammation, according to results from the first human ... Blood , the Journal of the ... is a condition that occurs when red blood cells are ... individual has anemia, the body does not get enough oxygen, ...
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire/ ... market research report is available in ... Guidebook for Application and Approval of ... to Practices (2014 Edition) ... Now, Chinese regulations on ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... PDII ), today reported financial and operational results ... Summary financial and operating highlights include: Full year ... 2011 and 2010 revenue excludes the company,s Pharmakon business unit, ... in discontinued operations. Full year 2011 operating loss of $4.7 ...
... March 7, 2012  The Starkey Hearing Foundation Israel-Palestine Hearing ... Palestinians together for a common cause to address a ... a year, Starkey Hearing Foundation, which strives to change ... visited the region in an effort to promote greater ...
Cached Medicine Technology:PDI Reports 2011 Fourth Quarter and Year End Financial Results 2PDI Reports 2011 Fourth Quarter and Year End Financial Results 3PDI Reports 2011 Fourth Quarter and Year End Financial Results 4PDI Reports 2011 Fourth Quarter and Year End Financial Results 5PDI Reports 2011 Fourth Quarter and Year End Financial Results 6PDI Reports 2011 Fourth Quarter and Year End Financial Results 7PDI Reports 2011 Fourth Quarter and Year End Financial Results 8PDI Reports 2011 Fourth Quarter and Year End Financial Results 9PDI Reports 2011 Fourth Quarter and Year End Financial Results 10Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 2Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 3Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 4Starkey Hearing Foundation Returns to Israel-Palestine to Promote Peace Through Better Hearing 5
(Date:8/27/2014)... Washington, DC (PRWEB) August 28, 2014 ... that Betty Pierce Dennis, DrPH, MN, RN, FAAN, became ... Nursing Center for the Advancement of the Science of ... one of seven that comprise the NLN Home for ... the nation’s capital a year ago. , Under ...
(Date:8/27/2014)... Delta, a reliable supplier of high quality ... D7R Dozers to its used bulldozer collection. ... that all these items are offered with deep discounts. ... Delta’s market share in the coming September. , ... offer; he has much confidence in the discounted Used ...
(Date:8/27/2014)... 27, 2014 Millennium Treatment Group is ... for Florida Mental Health Counselors Association (FMHCA). The addiction ... sponsorship is sure to provide. , FMHCA is an ... Florida’s licensed mental health counselors. The organization was founded ... Association (ACA) and since then, it has served the ...
(Date:8/27/2014)... Mamaroneck, NY (PRWEB) August 27, 2014 ... Mobility Team ) is holding free events about “ ... guest speaker Liz Treston. These straightforward and entertaining discussions ... pm at Bussani Mobility (501 Concord Avenue, Mamaroneck, NY) ... (500 Central Avenue, Bethpage, NY). , The New ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... released guidelines for the management and treatment of ... for Pulmonary Arterial Hypertension in Adults: CHEST Guideline, ... to view for clinicians, and provide the latest ... The Pulmonary Hypertension Association (PHA) – ...
Breaking Medicine News(10 mins):Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:Millennium Treatment Group Sponsors Florida Mental Health Counselors Association 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2
... factors associated with multiple sclerosis previously poorly understood ... alter a critical cellular function linked to the chronic ... Research Center have discovered. The findings, which appear ... a unifying mechanism may be responsible for multiple sclerosis ...
... finds that obese women reported significantly worse health than obese ... blacks in the normal or obese weight categories. Respondents were ... their height and weight. The survey results are ... Quality of Life Research and they come from a ...
... Elsevier, a world-leading publisher of scientific, technical and ... the launch of a new journal, International Journal ... Association. Published quarterly, the first issue of the journal ... ScienceDirect. Print copies of the first issue will be ...
... true that we know of around 70 different types of ... were diagnosed correctly when we began the study", say researchers ... study included 176 patients, the vast majority from the cities ... at specialist geriatric psychiatry clinics during the period 1996-2006 and ...
... has launched a network of job sites designed to ... audience that uses Springer tools which are some of ... research. With over 16 million unique visitors per month ... and medical specialities, Springer,s sites attract the candidates that ...
... 30, 2011 Private health clinics across Canada providing weight-loss ... hefty cost and at the expense of quality patient care, ... physician Dr. Chaim Bell. "The private clinics in ... that involves banding the upper stomach to restrict food intake ...
Cached Medicine News:Health News:UCI researchers find link between environment and genetics in triggering MS 2Health News:Extra weight equals better health-related quality of life for blacks, not so for women 2Health News:Elsevier launches new journal: International Journal of Paleopathology 2Health News:Difficulties in diagnosing dementia type 2Health News:Springer launches network of job sites 2Health News:Private weight-loss surgery clinics shedding quality patient care 2
The ACMI TurboFlow 18 L and 10 L Insufflators provide rapid distention for all laparoscopic procedures. Eleven built-in safety features make insufflation reliable and dependable....
Tongs...
... Ambient Noise Reduction (ANR)technology, internal to ... 75% of distracting room,noise, greatly enhancing ... is different from electronic filtering, which ... of body sounds clinicians need to ...
... leaded eyeglasses deliver superb radiation protection-0.62mm (+/- ... procedures. In addition to their level of ... light-weight and rest smoothly on your bridge ... If you normally wear corrective lenses, you ...
Medicine Products: